Related Experiment Videos
Hypertriglyceridemia enhances monocyte binding to endothelial cells in NIDDM
N Hoogerbrugge1, A Verkerk, M L Jacobs
1Department of Internal Medicine III, University Hospital Rotterdam Dijkzigt, The Netherlands. hoogerbrugge@inw3.azr.nl
Diabetes Care
|October 1, 1996
Summary
Hypertriglyceridemia in non-insulin-dependent diabetes mellitus (NIDDM) significantly increases monocyte adherence to endothelial cells, a key step in atherosclerosis development. Treating high triglycerides may reduce cardiovascular risk in these patients.
Area of Science:
- Cardiovascular Research
- Endocrinology
- Immunology
Background:
- Diabetes mellitus is linked to accelerated atherosclerosis.
- Monocyte adhesion to the arterial wall is an early pathogenic event.
- Mechanisms underlying diabetes-induced atherosclerosis require further elucidation.
Purpose of the Study:
- To investigate monocyte adherence to endothelial cells in patients with diabetes mellitus.
- To determine the influence of glycemic control, hypertriglyceridemia, and clinical factors on monocyte-endothelial cell interactions.
Main Methods:
- Isolated monocytes from patients with non-insulin-dependent diabetes mellitus (NIDDM), insulin-dependent diabetes mellitus (IDDM), and healthy controls.
- Assessed monocyte binding to human umbilical vein endothelial cells in vitro.
- Correlated adherence with serum triglyceride levels, glycemic control, age, sex, and atherosclerotic disease presence.
Main Results:
- Monocyte adherence was similar in normolipidemic IDDM and NIDDM patients compared to controls.
- Significantly increased monocyte adherence was observed in NIDDM patients with hypertriglyceridemia (serum triglycerides > 2.5 mmol/l).
- No correlation was found between monocyte adherence and glycemic control, age, sex, or symptomatic atherosclerosis.
Conclusions:
- Hypertriglyceridemia in NIDDM is associated with increased monocyte adherence.
- Targeting hypertriglyceridemia may be crucial for mitigating atherosclerosis risk in NIDDM.
- This finding highlights a specific mechanism linking metabolic dysregulation in diabetes to vascular inflammation.